Start Date
March 31, 2016
Primary Completion Date
June 30, 2016
Study Completion Date
May 31, 2017
Investigational H7N9 vaccine GSK3277510A
One dose of GSK3277510A H7N9 vaccine administered intramuscularly (IM) in the deltoid region of non-dominant arm at Day 0 and the second dose of GSK3277510A H7N9 vaccine administered IM in the deltoid region of dominant arm at Day 21
Investigational H7N9 vaccine GSK3277509A
One dose of GSK3277509A H7N9 vaccine administered IM at the deltoid region of non-dominant arm at Day 0 and the second dose of GSK3277509A H7N9 vaccine administered IM at the deltoid region of dominant arm at Day 21
Placebo
One dose of placebo administered IM at the deltoid region of non-dominant arm at Day 0 and the second dose of placebo administered IM at the deltoid region of dominant arm at Day 21
Lead Sponsor
GlaxoSmithKline
INDUSTRY